Description: Adjuvants for new and improved vaccines.- Liposome mediated immunopotentiation and immunomodulation.- Quil A, anti-carbohydrate antibody specificity and biological function.- Vaccine adjuvants based on gamma inulin.- Interleukin-2 as a co-adjuvant for liposomal tetanus toxoid.- Design of vaccines for the induction of antibody responses in Th-cell deficient individuals.- Strategies for the stimulation of Th cell subsets.- Feline immunodeficiency virus as a vaccine model.- Rational design of vaccine molecules to prevent pertussis.- Multicomponent viral vaccines and their use as immunogen delivery systems.- Vaccines against HPV of the uterine cervix: Problems in clinical applicability.- Local chemotherapy of lymph node metastases: Optimization of targeting accuracy.- Synthetic peptide vaccines: Success at last.- Peptide vaccines: New approaches to immunopotentiation.- Genetic restriction of responses to peptide antigens.- DNA-based immunization: Prospects for a hepatitis B vaccine.- Characterization of immune responses elicited by an experimental facilitated-DNA vaccine for human immunodeficiency virus type-1 (HIV-1).- Recombinant self-replicating RNA vaccines.

Please Wait